Story thread · 2 reports / 2 sources
Amgen's Repatha cuts death risk by 20% in heart study
seekingalpha.com · 15d
How the coverage leans
Across 2 sources · syndicated copies counted once
First report: One Of Amgen's Biggest Moneymakers Cuts The Risk Of Dying By 20% — investors.com, 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.